| BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting N Dagan, N Barda, E Kepten, O Miron, S Perchik, MA Katz, MA Hernán, ... New England Journal of Medicine, 2021 | 1804 | 2021 |
| Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting N Barda, N Dagan, Y Ben-Shlomo, E Kepten, J Waxman, R Ohana, ... New England Journal of Medicine, 2021 | 453 | 2021 |
| Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study N Barda, N Dagan, C Cohen, MA Hernán, M Lipsitch, IS Kohane, BY Reis, ... The Lancet 398 (10316), 2093-2100, 2021 | 431 | 2021 |
| Myocarditis after Covid-19 vaccination in a large health care organization G Witberg, N Barda, S Hoss, I Richter, M Wiessman, Y Aviv, T Grinberg, ... New England Journal of Medicine, 2021 | 270 | 2021 |
| Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy N Dagan, N Barda, T Biron-Shental, M Makov-Assif, C Key, IS Kohane, ... Nature medicine 27 (10), 1693-1695, 2021 | 119 | 2021 |
| Developing a COVID-19 mortality risk prediction model when individual-level data are not available N Barda, D Riesel, A Akriv, J Levy, U Finkel, G Yona, D Greenfeld, ... Nature communications 11 (1), 1-9, 2020 | 91* | 2020 |
| External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort … N Dagan, C Cohen-Stavi, M Leventer-Roberts, RD Balicer bmj 356, 2017 | 78 | 2017 |
| Effectiveness of BNT162b2 vaccine against delta variant in adolescents BY Reis, N Barda, M Leshchinsky, E Kepten, MA Hernán, M Lipsitch, ... New England Journal of Medicine 385 (22), 2101-2103, 2021 | 56 | 2021 |
| Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting O Magen, JG Waxman, M Makov-Assif, R Vered, D Dicker, MA Hernán, ... New England Journal of Medicine 386 (17), 1603-1614, 2022 | 40 | 2022 |
| Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization N Dagan, E Elnekave, N Barda, O Bregman-Amitai, A Bar, M Orlovsky, ... Nature medicine 26 (1), 77-82, 2020 | 36 | 2020 |
| Erbin is a negative modulator of cardiac hypertrophy I Rachmin, S Tshori, Y Smith, A Oppenheim, S Marchetto, G Kay, RSY Foo, ... Proceedings of the National Academy of Sciences 111 (16), 5902-5907, 2014 | 36 | 2014 |
| Effects of social network exposure on nutritional learning: development of an online educational platform N Dagan, D Beskin, M Brezis, BY Reis JMIR serious games 3 (2), e4002, 2015 | 31* | 2015 |
| BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply. N Barda, N Dagan, RD Balicer The New England Journal of Medicine 384 (20), 2021 | 30 | 2021 |
| Addressing bias in prediction models by improving subpopulation calibration N Barda, G Yona, GN Rothblum, P Greenland, M Leibowitz, R Balicer, ... Journal of the American Medical Informatics Association 28 (3), 549-558, 2021 | 27 | 2021 |
| Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting M Mittelman, O Magen, N Barda, N Dagan, HS Oster, A Leader, R Balicer Blood, The Journal of the American Society of Hematology 139 (10), 1439-1451, 2022 | 22 | 2022 |
| Adverse effects after BNT162b2 vaccine and SARS-CoV-2 infection, according to age and sex N Dagan, N Barda, RD Balicer New England Journal of Medicine 385 (24), 2299-2299, 2021 | 20 | 2021 |
| MHC haplotyping of SARS-CoV-2 patients: HLA subtypes are not associated with the presence and severity of COVID-19 in the Israeli population S Ben Shachar, N Barda, S Manor, S Israeli, N Dagan, S Carmi, R Balicer, ... Journal of clinical immunology 41 (6), 1154-1161, 2021 | 18 | 2021 |
| Indirect protection of children from SARS-CoV-2 infection through parental vaccination S Hayek, G Shaham, Y Ben-Shlomo, E Kepten, N Dagan, D Nevo, ... Science 375 (6585), 1155-1159, 2022 | 9 | 2022 |
| Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI) MA Katz, EB Harlev, B Chazan, M Chowers, D Greenberg, A Peretz, ... Vaccine 40 (3), 512-520, 2022 | 7 | 2022 |
| ICU Survival Prediction Incorporating Test-Time Augmentation to Improve the Accuracy of Ensemble-Based Models S Cohen, N Dagan, N Cohen-Inger, D Ofer, L Rokach IEEE Access 9, 91584-91592, 2021 | 5 | 2021 |
